Role of IL-6 trans-signaling in CCl₄induced liver damage.

[1]  Xin-Yuan Fu,et al.  Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell–specific signal transducer and activator of transcription 3 gene knockout mice , 2010, Hepatology.

[2]  Xin-Yuan Fu,et al.  Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity , 2010, Hepatology.

[3]  J. Scheller,et al.  Interleukin-6 trans-signaling regulates glycogen consumption after D-galactosamine-induced liver damage. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[4]  J. Scheller,et al.  Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis1 , 2009, The Journal of Immunology.

[5]  N. Nishimoto,et al.  Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. , 2008, Blood.

[6]  S. Rose-John,et al.  IL-6/IL-6R axis plays a critical role in acute kidney injury. , 2008, Journal of the American Society of Nephrology : JASN.

[7]  J. Scheller,et al.  Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. , 2008, Blood.

[8]  C. Fielding,et al.  Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. , 2007, Blood.

[9]  J. Scheller,et al.  The IL-6/sIL-6R complex as a novel target for therapeutic approaches , 2007, Expert opinion on therapeutic targets.

[10]  J. Scheller,et al.  Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer , 2006, Journal of leukocyte biology.

[11]  Y. Ohta,et al.  Preventive effect of neutropenia on carbon tetrachloride‐induced hepatotoxicity in rats , 2006, Journal of applied toxicology : JAT.

[12]  Stefan Wirtz,et al.  TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling , 2004 .

[13]  L. Weber,et al.  Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model , 2003, Critical reviews in toxicology.

[14]  M. Luster,et al.  The Role of Tumor Necrosis Factor-α in Liver Toxicity, Inflammation, and Fibrosis Induced by Carbon Tetrachloride , 2001 .

[15]  S. Rose-John,et al.  Hyper-IL-6 gene therapy reverses fulminant hepatic failure. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  P. Schirmacher,et al.  Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. , 2000, Gastroenterology.

[17]  S. Rose-John,et al.  Liver regeneration induced by a designer human IL‐6/ sIL‐6R fusion protein reverses severe hepatocellular injury , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Neurath,et al.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.

[19]  Gennaro Ciliberto,et al.  Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice , 2000, Hepatology.

[20]  A. Demetris,et al.  Mitosis and apoptosis in the liver of interleukin‐6–deficient mice after partial hepatectomy , 1999, Hepatology.

[21]  J. Chebath,et al.  Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. , 1998, Cytokines, cellular & molecular therapy.

[22]  S. Rose-John,et al.  A bioactive designer cytokine for human hematopoietic progenitor cell expansion , 1997, Nature Biotechnology.

[23]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.

[24]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[25]  B. F. Becker.  Towards the physiological function of uric acid. , 1993, Free radical biology & medicine.

[26]  U. Kodavanti,et al.  Carbon tetrachloride—induced alterations of hepatic calmodulin and free calcium levels in rats pretreated with chlordecone , 1991, Hepatology.

[27]  B. Halliwell,et al.  The measurement and mechanism of lipid peroxidation in biological systems. , 1990, Trends in biochemical sciences.

[28]  G. Bellomo,et al.  Effects of carbon tetrachloride on calcium homeostasis. A critical reconsideration. , 1989, Biochemical pharmacology.

[29]  B. Ames,et al.  Antioxidant defenses and lipid peroxidation in human blood plasma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Neurath,et al.  Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. , 2001, European journal of biochemistry.

[31]  R. O. Recknagel,et al.  Mechanisms of carbon tetrachloride toxicity. , 1989, Pharmacology & therapeutics.

[32]  R. Estabrook,et al.  CCl4−induced toxicity in isolated hepatocytes: The importance of direct solvent injury , 1986, Hepatology.

[33]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.